[
  {
    "molstructure": "\r\n  -ISIS-  01041217192D\r\n\r\n 25 27  0  0  0  0  0  0  0  0999 V2000\r\n    4.7542   -1.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.9292   -1.9875    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n   -0.1958   -1.9792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    5.1667   -2.7042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.1667   -1.2750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.5167   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.5125   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.2167   -1.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.2167   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.0125   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -2.2458   -1.2625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.4542   -1.9792    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.2792   -1.9792    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0\r\n    5.9917   -2.7042    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.6917   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.6917   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.0417   -1.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.0417   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.4250   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -2.6625   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.0667   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.7625   -2.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.4250   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -2.2458   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  9  1  0  0  0  0\r\n  4  1  1  0  0  0  0\r\n  5  1  2  0  0  0  0\r\n  6  2  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8 17  1  0  0  0  0\r\n  9 18  1  0  0  0  0\r\n 10  3  1  0  0  0  0\r\n 11 19  1  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13 15  1  0  0  0  0\r\n 14  4  1  0  0  0  0\r\n 15  7  1  0  0  0  0\r\n 16  6  1  0  0  0  0\r\n 17 12  1  0  0  0  0\r\n 18 12  1  0  0  0  0\r\n 19 10  2  0  0  0  0\r\n 20 25  1  0  0  0  0\r\n 21 14  1  0  0  0  0\r\n 22 14  1  0  0  0  0\r\n 23 14  1  0  0  0  0\r\n 24 10  1  0  0  0  0\r\n 25 24  2  0  0  0  0\r\n 16 13  1  0  0  0  0\r\n  8  3  1  0  0  0  0\r\n 11 20  2  0  0  0  0\r\nM  END",
    "cdbregno": "1",
    "id": "1",
    "mode_action": "GPR119 agonist",
    "source": "Journal",
    "year": "2011",
    "therapeutic_data": "type II diabetes, hyperglycemia,\r\nhyperlipidemia, obesity, hypertension, a\r\nrteriosclerosis",
    "journal_author": "Szewczyk, J.",
    "journal_name": "Bioorg Med Chem Lett",
    "journal_volume": "21",
    "journal_issue": "9",
    "journal_page": "2665â€“2669",
    "pubmedid": "21273063",
    "bioactivity": [
      {
        "receptor": "GPR119",
        "assay": "cAMP assay",
        "affinity": "3600",
        "function": "Agonist",
        "organism": "Human",
        "measure": "EC50",
        "unit": "nM"
      },
      {
        "receptor": "GPR119",
        "assay": "cAMP assay",
        "comments": "% activation at 10 uM",
        "affinity": "< 10%",
        "function": "Agonist",
        "organism": "Mouse",
        "measure": "Activation",
        "unit": "nM"
      }
    ]
  }
]
